학술논문
Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report
Document Type
Artikel
Author
Source
British journal of haematology. 189(4):689-693
Subject
Language
English
English
English
ISSN
1365-2141